PT  - JOURNAL ARTICLE
AU  - Rui Ding
AU  - Yi Xiao
AU  - Miao Mo
AU  - Ying Zheng
AU  - Yi-Zhou Jiang
AU  - Zhi-Ming Shao
TI  - Breast cancer screening and early diagnosis in Chinese women
AID  - 10.20892/j.issn.2095-3941.2021.0676
DP  - 2022 Apr 15
TA  - Cancer Biology & Medicine
PG  - 450--467
VI  - 19
IP  - 4
4099  - http://www.cancerbiomed.org/content/19/4/450.short
4100  - http://www.cancerbiomed.org/content/19/4/450.full
SO  - Cancer Biology & Medicine2022 Apr 15; 19
AB  - Breast cancer is the most common malignant tumor in Chinese women, and its incidence is increasing. Regular screening is an effective method for early tumor detection and improving patient prognosis. In this review, we analyze the epidemiological changes and risk factors associated with breast cancer in China and describe the establishment of a screening strategy suitable for Chinese women. Chinese patients with breast cancer tend to be younger than Western patients and to have denser breasts. Therefore, the age of initial screening in Chinese women should be earlier, and the importance of screening with a combination of ultrasound and mammography is stressed. Moreover, Chinese patients with breast cancers have several ancestry-specific genetic features, and aiding in the determination of genetic screening strategies for identifying high-risk populations. On the basis of current studies, we summarize the development of risk-stratified breast cancer screening guidelines for Chinese women and describe the significant improvement in the prognosis of patients with breast cancer in China.